PureTech Health PLC

As of June 30, 2026, PureTech Health PLC carries a market capitalization of 33.45B, placing it among publicly traded companies globally. Its enterprise value stands at 17.63B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

PureTech Health PLC's next confirmed earnings release is scheduled for April 29, 2027.

As of June 30, 2026, PureTech Health PLC has 243.42M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, PureTech Health PLC maintains a current ratio of 4.60, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, PureTech Health PLC's stock has declined approximately 13.32% over the past 52 weeks. The 50-day moving average sits at 117.02, while the 200-day moving average is 124.02.

As of June 30, 2026, PureTech Health PLC holds 16.69B in cash and equivalents against 1.38B in total debt, resulting in a net debt position of -8.74B. Total book value stands at 29.12B, with working capital of 14.89B providing operational flexibility.